Skip to content

The efficacy of percutaneous epidural adhesions and neuroplasty with isobaric solution for the failed back surgery syndrome.

The efficacy of percutaneous epidural adhesions and neuroplasty with isobaric solution for the failed back surgery syndrome.a single center. retrospective observation study. - The efficacy of percutaneous epidural adhesions and neuroplasty with isobaric solution for the failed back surgery syndrome.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000040500
Enrollment
21
Registered
2020-06-07
Start date
2020-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Failed back surgery syndrome (adults)

Interventions

None listed

Sponsors

Ebetsu city hospital department of painclinic and anesthesia
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Failed back surgery syndrome without spinal cord damage. 2.Japanese males and females aged over 20 years old. 3. Indivisuals whose written informed consent has been obtained . 4. Indivisuals judged appropriate for the study by the principal.

Exclusion criteria

Exclusion criteria: 1. Indivisuals with spinal cord dameged. 2. Indivisuals did not receive the percutaneous epidural lysis of adhesions and neuroplasty with isobaric solution.

Design outcomes

Primary

MeasureTime frame
Efficacy evaluations: Numerous rating scale of numbness and low back pain before the percutaneous epidural lysis of adhesions and neuroplasty with isobaric solution. Numerous rating scale of numbness and low back pain 24hours after the percutaneous epidural lysis of adhesions and neuroplasty with isobaric solution.

Countries

Japan

Contacts

Public Contactkoichi ota

Ebetsu city hospital department of painclinic and anesthesia

kota64998@gmail.com+81113825151

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026